WallStreetZenWallStreetZen

NYSE: NMR
Nomura Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their NMR stock forecasts and price targets.

Forecast return on equity

Is NMR forecast to generate an efficient return?

Company
1,535.7%
Industry
54.51%
Market
229.18%
NMR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NMR forecast to generate an efficient return on assets?

Company
93.84%
Industry
5.45%
NMR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NMR earnings per share forecast

What is NMR's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$123.83+15,940.3%
Avg 2 year Forecast
$119.09+15,325.61%
Avg 3 year Forecast
$124.52+16,029.65%
NMR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NMR revenue forecast

What is NMR's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$1.9T+15,140.67%
Avg 2 year Forecast
$1.9T+15,108.15%
Avg 3 year Forecast
$2.0T+15,431.36%
NMR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NMR earnings growth forecast

How is NMR forecast to perform vs Capital Markets companies and vs the US market?

Company
436.03%
Industry
20.26%
Market
42.83%
NMR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NMR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NMR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NMR revenue growth forecast

How is NMR forecast to perform vs Capital Markets companies and vs the US market?

Company
431.22%
Industry
19.43%
Market
25.64%
NMR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NMR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NMR vs Capital Market Stocks

TickerPricePrice TargetUp/downsideConsensus
NMR$7.75N/AN/A
FUTU$168.29$226.75+34.74%Strong Buy
CRCL$86.29$138.64+60.67%Buy
TW$108.06$135.36+25.27%Buy
LPLA$361.23$424.55+17.53%Strong Buy
View Top Capital Market Stocks

Nomura Holdings Stock Forecast FAQ

What is NMR's earnings growth forecast for 2026-2028?

(NYSE: NMR) Nomura Holdings's forecast annual earnings growth rate of 436.03% is forecast to beat the US Capital Markets industry's average forecast earnings growth rate of 20.26%, and it is also forecast to beat the US market's average forecast earnings growth rate of 42.83%.

Nomura Holdings's earnings in 2025 is $2,353,149,171.On average, 7 Wall Street analysts forecast NMR's earnings for 2026 to be $366,070,855,628, with the lowest NMR earnings forecast at $315,782,455,281, and the highest NMR earnings forecast at $412,524,459,111. On average, 7 Wall Street analysts forecast NMR's earnings for 2027 to be $352,042,452,115, with the lowest NMR earnings forecast at $306,222,069,020, and the highest NMR earnings forecast at $426,802,958,072.

In 2028, NMR is forecast to generate $368,110,049,952 in earnings, with the lowest earnings forecast at $306,222,069,020 and the highest earnings forecast at $439,839,848,428.

If you're new to stock investing, here's how to buy Nomura Holdings stock.

What is NMR's revenue growth forecast for 2026-2028?

(NYSE: NMR) Nomura Holdings's forecast annual revenue growth rate of 431.22% is forecast to beat the US Capital Markets industry's average forecast revenue growth rate of 19.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.64%.

Nomura Holdings's revenue in 2025 is $13,069,647,790.On average, 8 Wall Street analysts forecast NMR's revenue for 2026 to be $5,711,000,495,899,725, with the lowest NMR revenue forecast at $5,061,210,544,737,900, and the highest NMR revenue forecast at $6,371,580,617,083,800. On average, 8 Wall Street analysts forecast NMR's revenue for 2027 to be $5,698,812,038,091,030, with the lowest NMR revenue forecast at $5,304,565,831,376,700, and the highest NMR revenue forecast at $6,103,437,501,503,475.

In 2028, NMR is forecast to generate $5,819,928,001,327,080 in revenue, with the lowest revenue forecast at $5,445,009,501,901,920 and the highest revenue forecast at $6,276,641,901,942,825.

What is NMR's forecast return on assets (ROA) for 2026-2028?

(NYSE: NMR) forecast ROA is 93.84%, which is higher than the forecast US Capital Markets industry average of 5.45%.

What is NMR's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: NMR) Nomura Holdings's current Earnings Per Share (EPS) is $0.80. On average, analysts forecast that NMR's EPS will be $123.83 for 2026, with the lowest EPS forecast at $106.82, and the highest EPS forecast at $139.55. On average, analysts forecast that NMR's EPS will be $119.09 for 2027, with the lowest EPS forecast at $103.59, and the highest EPS forecast at $144.38. In 2028, NMR's EPS is forecast to hit $124.52 (min: $103.59, max: $148.79).

What is NMR's forecast return on equity (ROE) for 2026-2028?

(NYSE: NMR) forecast ROE is 1,535.7%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.